Mather Group, Llc. Novo Nordisk A S Transaction History

Mather Group, Llc.

$7.74 Billion
Q3 2024

A detailed history of Mather Group, Llc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mather Group, Llc. holds 5,835 shares of NVO stock, worth $598,846. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,835

Previous 5,592 4.35%

Holding current value

$598,846

Previous $798,000 13.03%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$119.07 - $145.42 $28,934 - $35,337	243 Added 4.35%	5,835 $694,000
Q2 2024 Jul 08, 2024	BUY	$122.71 - $146.91 $189,709 - $227,122	1,546 Added 38.21%	5,592 $798,000
Q1 2024 Apr 08, 2024	SELL	$102.11 - $135.92 $7,045 - $9,378	-69 Reduced 1.68%	4,046 $519,000
Q4 2023 Feb 05, 2024	SELL	$87.78 - $105.45 $497,098 - $597,163	-5,663 Reduced 57.92%	4,115 $425,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $449,061 - $985,328	4,938 Added 102.02%	9,778 $889,000
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $9,982 - $11,049	-64 Reduced 1.31%	4,840 $783,000
Q1 2023 May 09, 2023	SELL	$132.34 - $159.14 $67,096 - $80,683	-507 Reduced 9.37%	4,904 $780,000
Q4 2022 Mar 10, 2023	SELL	$102.55 - $135.33 $4,922 - $6,495	-48 Reduced 0.88%	5,411 $732,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $3,525 - $4,326	37 Added 0.68%	5,459 $544,000
Q2 2022 Aug 16, 2022	SELL	$103.24 - $121.81 $309 - $365	-3 Reduced 0.06%	5,422 $604,000
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $372 - $450	4 Added 0.07%	5,425 $602,000
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $383 - $468	4 Added 0.07%	5,421 $607,000
Q3 2021 Nov 04, 2021	SELL	$84.42 - $106.62 $28,196 - $35,611	-334 Reduced 5.81%	5,417 $520,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $6,766 - $8,476	-100 Reduced 1.71%	5,751 $482,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $136,668 - $154,521	-2,038 Reduced 25.83%	5,851 $394,000
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $95,962 - $110,847	-1,502 Reduced 15.99%	7,889 $551,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $292,209 - $322,169	-4,588 Reduced 32.82%	9,391 $652,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $818,330 - $949,733	13,979 New	13,979 $915,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account